Phagro, the German drug wholesalers' federation, is opposing efforts to change the national drug distribution system. Some German health funds have argued recently that further health care savings can be made by revamping the manufacturer-wholesaler- pharmacist system.
Phagro director Herman Ringenaldus says the present system offers an "optimal" form of drug supply. He claims that direct distribution would bring more disadvantages than advantages. Meanwhile, Phagro is forecasting average drug sales growth of 5% in 1994. Sales last year fell from 27.3 billion Deutschemarks to 24.7 billion marks ($16.28 billion).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze